| 영문 | outer ear, external ear | 한글 | 바깥귀, 외이 |
|---|---|---|---|
| 설명 | 귀는 바깥의 바깥귀, 그리고 음을 전달하는 가운데귀 그리고 전달된어진 소리를 신경이 알아들을 수 있도록 바꿔주는 기능을 가진 속귀, 이 3가지로 구분된다. 바깥귀는 그냥 밖에서 보이는 부분이며, 외이는 바깥 2/3는 연골로 구성되어 있고 안쪽 1/3은 뼈로 구성되어 있다. |
||
| 영문 | secondary infection | 한글 | 이차감염 |
|---|---|---|---|
| 설명 | 어떤 병원체의 감염에 의하여 본인의 저항력이 약해졌을 때 몸의 다른 부위로 전이하여 다시 감염을 일으키는 것. 병원체가 인체에 침입하여 특정한 기관이나 조직에서 병원체가 증식하고, 그곳에 특유의 병터를 일으키는 것이 1차감염 또는 초감염이다. 이 1차감염의 병터의 병원체가 혈관-림프관-기관-소화관-요관 등의 길을 따라 같은 기관의 다른 부위나 다른 기관으로 운반되어 감염을 일으킨다. 따라서 1차감염에 의하여 충분한 면역이 될 경우에는 2차감염이 일어나지 않는다. 예를 들어, 유행성 감기에 걸렸을 때 세균에 의한 폐렴이 뒤따르는 경우를 이른다. 폐렴균, 화농알균, 대장균 따위가 있다. |
||
| 영문 | parkinsonism | 한글 | 파킨슨증 |
|---|---|---|---|
| 설명 | 파킨슨병과는 다른 것으로, 뇌혈관성이나 약물성 등의 증후군(이차성)과 파킨슨병, 즉 무동, 근육강직, 떨림 등의 임상증상을 동반한 중추신경변성 병에 대한 명칭이다. 임상증상의 하나로서 파킨슨 증후군을 나타내는 변성병이 대부분을 차지하며, 파킨슨병에서는 나타나지 않는 피라밋로증상, 실조 등의 신경증상을 확인할 수 있다. 치매의 합병 빈도는 20% 전후이며, 뇌파이상이 나타난다. 1817년 영국의 J. 파킨슨이 보고한 것으로 유전성도 고려되는 병으로 치매와 함께 치명적인 노인병으로 알려져 있다. 또 같은 증세가 유행성 뇌염(일본뇌염), 뇌매독, 일산화탄소중독, 망간중독, 윌슨병 등 일 때에도 나타난다. 발병률은 1천명 중의 한 명꼴로 연령이 높을 수록 발생빈도가 높다. 50세 이상에서는 백병 중 한명의 발병률을 보이고 있다. |
||
| SA | salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame... |
|---|---|
| EC | effective concentration; ejection click; electrochemical; electron capture; embryonal carcinoma; eme... |
| ECP | ectrodactyly-cleft palate [syndrome]; effector cell precursor; endocardial potential; eosinophil cat... |
| ER | efficiency ratio; epigastric region; ejection rate; electroresection; emergency room; endoplasmic re... |
| OHA | Oral Hypoglycemic Agents |
| DUE | DNA unwinding element |
|---|---|
| DUE | Drug usage evaluation |
| CWA | Chemical warfare agents |
| DBA | Dentin bonding agents |
| DRO | Differential Reinforcement of Other Behaviour |
| parkinsonism | <neurology> A group of neurological disorders characterised by hypokinesia, tremor and muscular rigidity. (18 Nov 1997) |
|---|---|
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
| transferases (other substituted phosphate groups) | <enzyme> A class of enzymes that transfers substituted phosphate groups. Registry number: EC 2.7.8 (12 Dec 1998) |
| due date | The estimated calendar date when a baby will be born, the date the baby is due to be born. It is also called the estimated date of confinement (EDC). (12 Dec 1998) |
| dystonia, focal, due to blepharospasm | The second most common focal dystonia, the involuntary, forcible closure of the eyelids. The first symptoms may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal. (12 Dec 1998) |
| dystonia, focal, due to torticollis | Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward. (12 Dec 1998) |
| thrombotic disease due to protein c deficiency | Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal. (12 Dec 1998) |
| abortifacient agents | Chemical substances that interrupt pregnancy after implantation. (12 Dec 1998) |
| abortifacient agents, non-steroidal | Non-steroidal chemical compounds with abortifacient activity. (12 Dec 1998) |
| abortifacient agents, steroidal | Steroidal compounds with abortifacient activity. (12 Dec 1998) |
| adrenergic agents | Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (12 Dec 1998) |
| alkylating agents | Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agent, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (12 Dec 1998) |
| anti-allergic agents | Agents that are used to treat allergic reactions. most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (12 Dec 1998) |
| anti-allergic and respiratory system agents | A collective term for drugs used to treat allergic reactions as well as those drugs that produce an effect on the respiratory system. (12 Dec 1998) |
| anti-anxiety agents | Agents that alleviate anxiety, tension, and neurotic symptoms, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anaesthesia adjuvants. Adrenergic beta-antagonists are commonly used in the symptomatic treatment of anxiety but are not included here. Substances with a benzodiazepine ring structure widely used to treat anxiety and neuroses. Drugs in this class also generally have sedative or weak hypnotic properties and may be effective as muscle relaxants, anticonvulsants, and anaesthesia adjuvants. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|